Advertisement

Primary Angioplasty

  • Sorin J. Brener
  • Eric J. Topol
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

Acute myocardial infarction (AMI) affects 1.5 million people in the United States alone every year. Of those patients who seek (and reach) medical attention, approximately 25–50% present with typical ST-segment elevation on their initial electrocardiogram (ECG), within 12 h of symptom onset, and are candidates for pharmacologic or mechanical revascularization. Rapid and effective reperfusion can be achieved with fibrinolytic therapy or primary (direct) angioplasty, as demonstrated in numerous randomized trials and registries. A voluminous body of literature is devoted to the comparative analysis of the two strategies, in an effort to select the optimal therapy for patients with AMI.

Keywords

Acute Myocardial Infarction Acute Myocardial Infarction Cardiogenic Shock Fibrinolytic Therapy Primary Angioplasty 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311–322.Google Scholar
  2. 2.
    The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673–682.CrossRefGoogle Scholar
  3. 3.
    ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS 3: a randomized trial of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,290 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753.CrossRefGoogle Scholar
  4. 4.
    Gruppo Italiano per to Studio della Sopravvivenza nell’Infarto Miocardico. GISSI 2: a factorial randomized trial of alteplase vs. streptokinase and heparin vs. no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990; 336: 65.Google Scholar
  5. 5.
    Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993; 72: 13G - 21G.CrossRefPubMedGoogle Scholar
  6. 6.
    Boersma E, Maas CP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771–775.CrossRefPubMedGoogle Scholar
  7. 7.
    Gruppo Italiano per to Studio della Sopravvivenza nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397–401.Google Scholar
  8. 8.
    Boissel JP. The European Myocardial Infarction Project: an assessment of pre-hospital thrombolysis. Int J Cardiol 1995; 49: S29–37.CrossRefPubMedGoogle Scholar
  9. 9.
    GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 1992; 305: 548–553.CrossRefGoogle Scholar
  10. 10.
    GUSTO Angiographie Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–1621.CrossRefGoogle Scholar
  11. 11.
    Simes RJ, Topol EJ, Holmes DR Jr, et al Link between the angiographie substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995; 91: 1923–1928.CrossRefPubMedGoogle Scholar
  12. 12.
    Lincoff AM, Topol EJ, Califf RM, et al. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow “patency” (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Am J Cardiol 1995; 75: 871–876.CrossRefPubMedGoogle Scholar
  13. 13.
    Anderson JL, Karagounis LA, Califf RM. Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 1996; 78: 1–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699–1705.CrossRefPubMedGoogle Scholar
  15. 15.
    Lincoff MA, Topol EJ. Illusion of reperfusion (does anyone achieve optimal reperfusion during acute myocardial infarction?). Circulation 1993; 88: 1361–1374.CrossRefPubMedGoogle Scholar
  16. 16.
    GUSTO-IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621–1628.CrossRefGoogle Scholar
  17. 17.
    Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673–679.CrossRefPubMedGoogle Scholar
  18. 18.
    Laster SB, O. Keefe JH J, Gibbons RJ. Incidence and importance of thrombolysis in myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996; 78: 623–626.CrossRefPubMedGoogle Scholar
  19. 19.
    DeWood M, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897–902.CrossRefPubMedGoogle Scholar
  20. 20.
    Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med 1996; 335: 1198–1205.CrossRefPubMedGoogle Scholar
  21. 21.
    De Jaegere PP, Arnold AA, Balk AH, Simoons ML. Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors [see comments]. J Am Coll Cardiol 1992; 19: 289–294.CrossRefPubMedGoogle Scholar
  22. 22.
    Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per to Studio della Sopravvivenza nell’Infarto Miocardico II (GISSI-2), and The International Study. N Engl J Med 1992; 327: 1–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global use of strategies to open occluded coronary arteries. Circulation 1995; 92: 2811–2818.CrossRefPubMedGoogle Scholar
  24. 24.
    Rothbaum D, Linnemeier T, Landin R, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987; 10: 264–272.CrossRefPubMedGoogle Scholar
  25. 25.
    Ellis S, O’Neill W, Bates E, et al. Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1989; 13: 1251–1259.CrossRefPubMedGoogle Scholar
  26. 26.
    Kahn J, Rutherford B, McConahay D, et al. Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. J Am Coll Cardiol 1990; 16: 1089–1096.CrossRefPubMedGoogle Scholar
  27. 27.
    Beauchamp G, Vacek J, Robuck W. Management comparison for acute myocardial infarction: direct angioplasty versus sequential thrombolysis-angioplasty. Am Heart J 1990; 120: 237–242.CrossRefPubMedGoogle Scholar
  28. 28.
    O’Keefe JH, Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. Am J Cardiol 1993; 72: 107G - 115G.CrossRefPubMedGoogle Scholar
  29. 29.
    O’Neill W, Brodie B, Ivanhoe R, et al. Primary coronary angioplasty for acute myocardial infarction (the primary angioplasty registry). Am J Cardiol 1994; 73: 627–634.CrossRefPubMedGoogle Scholar
  30. 30.
    Brodie B, Grines C, Ivanhoe R, et al. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction (final results from the primary angioplasty registry). Circulation 1994; 90: 156–162.CrossRefPubMedGoogle Scholar
  31. 31.
    Every NR, Parsons LS, Hlatky M, Martin JS, Weaver DW, for the MITI Investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996; 335: 1253–1260.CrossRefPubMedGoogle Scholar
  32. 32.
    Rogers WJ, Dean LS, Moore PB, Wool KJ, Burgard SL, Bradley EL. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Alabama Registry of Myocardial Ischemia Investigators. Am J Cardiol 1994; 74: 111–118.CrossRefPubMedGoogle Scholar
  33. 33.
    Neuhaus K-L, Vogt A, Harmajanz D, et al. Primary PTCA in acute myocardial infarction: results from a German multicenter registry. J Am Coll Cardiol 1996; 27: 62A (abstract).Google Scholar
  34. 34.
    Zahn R, Koch A, Rustige J, et al. Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction. Am J Cardiol 1997; 79: 264–269.CrossRefPubMedGoogle Scholar
  35. 35.
    Nakagawa Y, Iwasaki Y, Kimura T, et al. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction. Am J Cardiol 1996; 78: 980–984.CrossRefPubMedGoogle Scholar
  36. 36.
    Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1997; 29: 1459–1467.CrossRefPubMedGoogle Scholar
  37. 37.
    DeWood MA. Direct PTCA vs. intravenous tPA in acute myocardial infarction: results from a prospective randomized trial., Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium, George Washington University, 1990.Google Scholar
  38. 38.
    Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680–684.CrossRefPubMedGoogle Scholar
  39. 39.
    Ribeiro EE, Silva LA, Carneiro R, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376–380.CrossRefPubMedGoogle Scholar
  40. 40.
    Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 1993; 328: 685–691.CrossRefPubMedGoogle Scholar
  41. 41.
    Garcia EJ, Delcan JL, Elizaga J, et al. [Primary coronary angioplasty in acute anterior myocardial infarction: immediate results]. Rev Esp Cardiol 1994; 47: 40–46.PubMedGoogle Scholar
  42. 42.
    Grinfeld L, Berrocal D, Belardi J, et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): a randomized trial in a community hospital in Argentina. J Am Coll Cardiol 1996; 27: 222A (abstract).Google Scholar
  43. 43.
    Ribichini F, Steffenino G, Dellavalle A, et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST-segment depression, a single-center randomized study. J Am Coll Cardiol 1996; 27: 221A (abstract).Google Scholar
  44. 44.
    Zijlstra F, Beukema WP, van’t Hof AW, et al. Randommized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997; 27: 908–912.CrossRefGoogle Scholar
  45. 45.
    Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative view. JAMA 1997; 278: 2093 2098.Google Scholar
  46. 46.
    Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995; 25: 370–377.CrossRefPubMedGoogle Scholar
  47. 47.
    Nunn C, O’Neill W, Rothbaum D, et al. Primary angioplasty for myocardial infarction improves longterm survival: PAMI-1 follow-up. J Am Coll Cardiol 1996; 27: 153A (abstract).Google Scholar
  48. 48.
    Anderson JL, Karagounis LA, Muhlestein JB. Explaining discrepant mortality results between primary percutaneous transluminal coronary angioplasty and thrombolysis for acute myocardial infarction [editorial]. Am J Cardiol 1996; 78: 934–939.CrossRefPubMedGoogle Scholar
  49. 49.
    Cannon CP, Lambrew CT, Tiefenbrunn AJ, et al. Influence of door-to-balloon time on mortality in primary angioplasty results in 3,648 patients in the second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1996; 27: 61A (abstract).Google Scholar
  50. 50.
    Mueller DWM, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med 1990; 113: 949–960.CrossRefGoogle Scholar
  51. 51.
    Lieu TA, Gurley RJ, Lundstrom RJ, Parmley WW. Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary. J Am Coll Cardiol 1996; 27: 737–750.CrossRefPubMedGoogle Scholar
  52. 52.
    Chandra H, Yarzebski Y, Goldberg RJ, et al. Age-related trends (1986–1993) in the use of thrombolytic agents in patients with acute myocardial infarction. Arch Int Med 1997; 1157: 9977–41746.Google Scholar
  53. 53.
    Cragg D, Friedman H, Bonema J, et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991; 115: 173–177.CrossRefPubMedGoogle Scholar
  54. 54.
    O’Gara PT. Acute myocardial Infarction: primary pump failure. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease, vol. 2. Lipppincott-Raven, Philadelphia, 1996, pp. 1051–1064.Google Scholar
  55. 55.
    Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation 1995; 91: 873–881.CrossRefPubMedGoogle Scholar
  56. 56.
    Califf RM, Bengston JR. Cardiogenic shock. N Engl J Med 1994; 330: 1724.CrossRefPubMedGoogle Scholar
  57. 57.
    Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988 [see comments]. N Engl J Med 1991; 325: 1117–1122.CrossRefPubMedGoogle Scholar
  58. 58.
    Group ATS. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988; 1: 545–549.Google Scholar
  59. 59.
    Wilcox RG, van der Lippe G, Olssen CG, et al. Trial of tissue-plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis. ASSET. Lancet 1988; 1: 525–530.CrossRefGoogle Scholar
  60. 60.
    Group TIS. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. The International Study Group. Lancet 1990; 336: 71–75.CrossRefGoogle Scholar
  61. 61.
    Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26: 668–674.CrossRefPubMedGoogle Scholar
  62. 62.
    O’Gara PT. Primary pump failure. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease, vol. 2. Lippincott-Raven, Philadelphia, 1996, pp. 1051–1064.Google Scholar
  63. 63.
    McCullough PA, O’Neill WW, Graham M, et al. A prospective randomized trial of triage angiography in suspected acute myocardial infarction patients who are ineligible for reperfusion therapy. Circulation 1996; 94: I - 570 (abstract).Google Scholar
  64. 64.
    Grimes CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 27: 1381–1386.CrossRefGoogle Scholar
  65. 65.
    Kaplan BM, Larkin T, Safian RD, et al. Prospective study of extraction atherectomy in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 383–388.CrossRefPubMedGoogle Scholar
  66. 66.
    Fischman D, Leon M, Baim D, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496–501.CrossRefPubMedGoogle Scholar
  67. 67.
    Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489–495.CrossRefPubMedGoogle Scholar
  68. 68.
    Hoorntje JC, Suryapranata H, de Boer M-J, Zijlstra F, van’t Hof AW, van den Brink L. ESCOBAR: primary stenting for acute myocardial infarction: preliminary results of a randomized trial. Circulation 1996; 94: I - 570 (abstract).Google Scholar
  69. 69.
    Rodriguez A, Fernandez M, Bernardi V, et al. Coronary stents improved hospital results during coronary angioplasty in acute myocardial infarction: preliminary results of a randomized controlled study (GRAMI Trial). J Am Coll Cardiol 1997; 29: 221A (abstract).Google Scholar
  70. 70.
    Saito S, Hosokawa G, Myiake S, Yamamoto S. Successful reperfusion with transradial angioplasty safely results in early ambulation and shortened hospital stay in a selected subgroup of acute myocardial infarction-the results of Kamakura PASTA trial. J Am Coll Cardiol 1997; 29: 235A (abstract).Google Scholar
  71. 71.
    Antoniucci D, Santoro GM, Bolognese L, et al. Elective stenting in acute myocardial infarction: preliminary results in the Florence Randomized Elective Stenting in Acute Coronary Occlusion (FRESCO) study. J Am Coll Cardiol 1997; 29: 456A (abstract).Google Scholar
  72. 71a.
    Grines CL, Cox D, Fernandez EG, et al. Primary angioplasty in Myocardial Infarction Trial (Stent- PAMI). Presented at the American College of Cardiology 47th Annual Scientific Session, 1998.Google Scholar
  73. 72.
    Benzuly KH, O’Neill WW, Gangadhran V, et al. Stenting in acute myocardial infarction (STAMI): bailout, conditional and planned stents. J Am Coll Cardiol 1996; 29: 456A (abstract).Google Scholar
  74. 73.
    Stone GW, Brodie B, Griffin J, et al. A prospective, multicenter trial of primary stenting in acute myocardial infarction—the PAMI Stent Pilot Study. Circulation 1996; 94: I - 570 (abstract).Google Scholar
  75. 74.
    Lefkovits J, Ivanhoe RJ, Califf RM, et al. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators. Am J Cardiol 1996; 77: 1045–1051.CrossRefPubMedGoogle Scholar
  76. Brener SJ, Barr LA, Burchenal JEB, Katz S, George B, Jones A, et al. A randomized, placebo-controlled trial of platelet glycoprotein IIb/Illa blockade with primary angioplasty for acute myocardial infarction. (ReoPro and Primary PTCA Organization and Randomized Trial [RAPPORT] investigators.) Circulation 1998; in press.Google Scholar
  77. 75.
    Lieu TA, Lundstrom RJ, Ray T, Fireman BH, Gurley RJ, Parmley WW. Initial cost of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1996; 28: 882–889.CrossRefPubMedGoogle Scholar
  78. 76.
    Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative cost and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 1997; 29: 901–907.CrossRefPubMedGoogle Scholar
  79. 77.
    de Boer Mi, van Hout BA, Liem AL, Suryapranata H, Hoorntje JC, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995; 76: 830–833.CrossRefGoogle Scholar
  80. 78.
    Mark DB, Granger CB, Ellis SE, et al. Costs of direct angioplasty versus thrombolysis for acute myocardial infarction: results from the GUSTO II randomized trial. Circulation 1996; 94: I - 168 (abstract).CrossRefGoogle Scholar
  81. 79.
    Ryan TJ, Anderson JL, Antmann EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996; 28: 1328–1428.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Sorin J. Brener
  • Eric J. Topol

There are no affiliations available

Personalised recommendations